EUVIMEDEUVIMED entdecken
Crossref

Surgical Margin Width Does Not Impact Local Recurrence Across Tumor Subtypes After Neoadjuvant Systemic Treatment and Breast‐Conserving Surgery

Adela-Luciana Oprea iD, Canan Aral iD, Yusuf Emre Aytin iD, Suleyman Bademler, Hasan Karanlik iD, M Umit Ugurlu iD, Atakan Sezer iD, Tiberiu-Bogdan Szekely iD, Rares Georgescu iD, Bahadir M Gulluoglu

World Journal of Surgery · 10.11.2026

DOI: 10.1002/wjs.70615 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Surgery, online erschienen am 10.11.2026. Verfasst von Adela-Luciana Oprea und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medex Oncology Hospital, Târgu Mureş, Romania. Die Arbeit nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Neoadjuvant systemic treatment (NAST) is the standard of care for patients with large tumors and/or regional lymph node involvement, particularly in those with HER2‐positive or triple‐negative breast cancer. A key advantage of NAST is tumor downstaging, which facilitates breast‐conserving surgery (BCS). However, the impact of surgical margin width on local recurrence rates across different tumor subtypes remains unclear.

Methods

This study retrospectively evaluated the rate of in‐breast invasive tumor recurrence (IITR) following BCS in patients of all tumor subtypes who received NAST. Patients with T 1–4a–c N 0–1 M 0 breast cancer who received NAST followed by BCS and locoregional radiotherapy were included. Two comparisons were performed: (1) patients with IITR versus those without, to identify factors related to recurrence; and (2) patients within each tumor subtype, to examine IITR rates according to surgical margin width.

Results

Among 429 patients (median age 48 years; range, 26–75) with a median follow‐up of 55 months (range, 4–199), IITR occurred in 16 patients (3.7%). IITR rates were similar across subtypes: 2.8% ( n = 6) in HR+/HER2−, 6.3% ( n = 5) in HR+/HER2+, 4.0% ( n = 2) in HR−/HER2+, and 3.7% ( n = 3) in triple‐negative tumors. No significant difference in IITR rates was found when stratified by surgical margin width within each subtype. Younger patient age was the only factor significantly associated with IITR. Breast cancer–specific mortality was significantly higher among patients with HR−/HER2+ and triple‐negative tumors compared with those with HR + tumors.

Conclusion

IITR was infrequent among patients undergoing BCS after NAST. Minimal clear margins (no ink on tumor) were found to be safe across all tumor subtypes in cases without complete response to NAST. Younger age was independently associated with higher IITR risk, regardless of margin width or tumor subtype.

Schlagwörter

Stichwörter der Autor:innen

breast conserving surgeryin‐breast tumor recurrenceneoadjuvant systemic treatmentsurgical margin

Autor:innen und Institutionen

  • Medex Oncology Hospital, Târgu Mureş, Romania.
  • General Surgery Unit, Boyabat State Hospital, Sinop, Turkiye.
  • Department of Surgery, Trakya University School of Medicine, Edirne, Turkiye.
  • Department of Surgical Oncology, Istanbul University Institute of Oncology, Istanbul, Turkiye.
  • Department of Surgery, Marmara University School of Medicine, Istanbul, Turkiye.
  • Department of Medical Oncology, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mureş, Târgu Mureş, Romania.

ORCID-Profile: Adela-Luciana Oprea, Canan Aral, Yusuf Emre Aytin, Hasan Karanlik, M Umit Ugurlu, Atakan Sezer, Tiberiu-Bogdan Szekely, Rares Georgescu

Zitieren

APA

Oprea, A. L., Aral, C., Aytin, Y. E., Bademler, S., Karanlik, H., Ugurlu, M. U., Sezer, A., Szekely, T. B., Georgescu, R., & Gulluoglu, B. M. (2026). Surgical Margin Width Does Not Impact Local Recurrence Across Tumor Subtypes After Neoadjuvant Systemic Treatment and Breast‐Conserving Surgery. World Journal of Surgery. https://doi.org/10.1002/wjs.70615

Vancouver

Oprea AL, Aral C, Aytin YE, Bademler S, Karanlik H, Ugurlu MU, et al. Surgical Margin Width Does Not Impact Local Recurrence Across Tumor Subtypes After Neoadjuvant Systemic Treatment and Breast‐Conserving Surgery. World Journal of Surgery. 2026. doi:10.1002/wjs.70615

BibTeX
@article{Oprea2026,
  author = {Oprea, Adela-Luciana and Aral, Canan and Aytin, Yusuf Emre and Bademler, Suleyman and Karanlik, Hasan and Ugurlu, M Umit and Sezer, Atakan and Szekely, Tiberiu-Bogdan and Georgescu, Rares and Gulluoglu, Bahadir M},
  title = {Surgical Margin Width Does Not Impact Local Recurrence Across Tumor Subtypes After Neoadjuvant Systemic Treatment and Breast‐Conserving Surgery},
  journal = {World Journal of Surgery},
  year = {2026},
  doi = {10.1002/wjs.70615}
}
Kostenlos starten →